Skip to content
2000
Volume 2, Issue 1
  • ISSN: 2212-7070
  • E-ISSN: 2212-7089

Abstract

Exacerbations of asthma are treated with oral corticosteroid medications which are associated with various adverse effects that impact negatively on patient adherence. Historically oral corticosteroid use has been associated with weight gain, increased appetite and dietary intake, though new evidence suggests that these effects are not associated with short term use. Impaired response to oral corticosteroids is also an issue in some patients due to steroid resistance. A new study suggests that inflammometry can be used to guide patient selection for oral corticosteroid therapy to improve responses. While oral corticosteroids remain the mainstay of treating asthma exacerbations, clinicians should give consideration to using inflammometry for patient selection and providing guidance on the likelihood and management of adverse effects.

Loading

Article metrics loading...

/content/journals/ciemd/10.2174/2212707002666150713173515
2015-06-01
2025-09-30
Loading full text...

Full text loading...

/content/journals/ciemd/10.2174/2212707002666150713173515
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test